Bioventus Inc. (Nasdaq:BVS)

Health Care/Life Sciences • Medical Equipment/Supplies

CIK 1665988

Company

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Address
4721 Emperor Boulevard
Suite 100
Durham, North Carolina 27703

Employees
1,120

Stock Info

Close
$5.52

Day Range
5.18 - 5.60

52 Week Range
0.80 - 5.60

Average volume
151.1K

Short Interest
835.06K (02/15/24)

% of Float Shorted
2.35%

Market Cap
$406.36M

Revenue
$512.12M

Net Income
-$158.7M

2020 Sales Growth
N/A

Rev. per Employee
$448.89K

P/E Ratio
N/A

EPS
-$2.93

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Robert Claypoole MBA

Chairman
William A Hawkins III, MBA

Independent Director
Philip G Cowdy

Independent Director
Guido J Neels MBA

Independent Director
Guy Paul Nohra MBA

Independent Director
Martin P Sutter MBA, CPA

Independent Director
Patrick Joseph Beyer MBA

Independent Director
Susan M Stalnecker MBA

Independent Director
Michelle McMurry-Heath MD, PhD

Independent Director
John Anders Bartholdson MBA

Independent Director
Mary Kay Ladone

SEC filings

Date	Form	Event
4 Oct, 2024	8-K
20 Aug, 2024	4
6 Aug, 2024	10-Q
6 Aug, 2024	8-K
19 Jul, 2024	8-K
15 Jul, 2024	SC 13G/A
25 Jun, 2024	4
25 Jun, 2024	4
25 Jun, 2024	4
24 Jun, 2024	4
24 Jun, 2024	4
24 Jun, 2024	4
21 Jun, 2024	8-K
21 Jun, 2024	4
21 Jun, 2024	4
21 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
17 Jun, 2024	8-K
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
11 Jun, 2024	4
10 Jun, 2024	4
3 Jun, 2024	DEFA14A
7 May, 2024	8-K
7 May, 2024	10-Q
26 Apr, 2024	ARS
26 Apr, 2024	DEF 14A
26 Apr, 2024	DEFA14A
15 Apr, 2024	4
15 Apr, 2024	4
15 Apr, 2024	4
12 Apr, 2024	4
12 Apr, 2024	4
12 Apr, 2024	4
11 Apr, 2024	144
11 Apr, 2024	144
11 Apr, 2024	144
10 Apr, 2024	PRE 14A
27 Mar, 2024	144
25 Mar, 2024	4
25 Mar, 2024	144
22 Mar, 2024	4
22 Mar, 2024	4
22 Mar, 2024	4
20 Mar, 2024	4
20 Mar, 2024	4
20 Mar, 2024	S-8
18 Mar, 2024	4
18 Mar, 2024	4
12 Mar, 2024	10-K
12 Mar, 2024	8-K
14 Feb, 2024	SC 13G/A
6 Feb, 2024	SC 13G/A
22 Jan, 2024	SC 13G/A
12 Jan, 2024	4
12 Jan, 2024	8-K	CEO Change
12 Jan, 2024	3
9 Jan, 2024	S-8
21 Dec, 2023	8-K	CEO Change
7 Nov, 2023	10-Q
7 Nov, 2023	8-K
23 Aug, 2023	3/A
23 Aug, 2023	4/A
22 Aug, 2023	4
18 Aug, 2023	4
15 Aug, 2023	4
15 Aug, 2023	4
14 Aug, 2023	4
8 Aug, 2023	10-Q
8 Aug, 2023	8-K
5 Jul, 2023	4
29 Jun, 2023	3
22 Jun, 2023	4
22 Jun, 2023	4
22 Jun, 2023	4
16 Jun, 2023	S-8
16 Jun, 2023	SC 13D/A
16 Jun, 2023	4
14 Jun, 2023	4
13 Jun, 2023	4
9 Jun, 2023	8-K
8 Jun, 2023	4
8 Jun, 2023	4/A
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
26 May, 2023	4
26 May, 2023	8-K
24 May, 2023	4
24 May, 2023	SC 13D/A
23 May, 2023	4
16 May, 2023	10-Q
16 May, 2023	8-K
16 May, 2023	8-K
11 May, 2023	8-K
11 May, 2023	NT 10-Q
27 Apr, 2023	DEF 14A
27 Apr, 2023	DEFA14A
21 Apr, 2023	4/A
21 Apr, 2023	4
21 Apr, 2023	4
21 Apr, 2023	4
18 Apr, 2023	S-8
12 Apr, 2023	4
12 Apr, 2023	4
12 Apr, 2023	4
12 Apr, 2023	4
11 Apr, 2023	8-K/A
10 Apr, 2023	3
5 Apr, 2023	4
5 Apr, 2023	8-K	CEO Change
31 Mar, 2023	10-K
31 Mar, 2023	8-K
27 Mar, 2023	4
23 Mar, 2023	4
16 Mar, 2023	4
16 Mar, 2023	4
16 Mar, 2023	NT 10-K
16 Mar, 2023	4
16 Mar, 2023	4
3 Mar, 2023	8-K
28 Feb, 2023	8-K
14 Feb, 2023	SC 13G
7 Feb, 2023	SC 13G/A
10 Jan, 2023	4
10 Jan, 2023	3
9 Jan, 2023	8-K
7 Dec, 2022	8-K
21 Nov, 2022	8-K/A
21 Nov, 2022	10-Q
16 Nov, 2022	NT 10-Q
16 Nov, 2022	8-K
15 Nov, 2022	SC 13D/A
8 Nov, 2022	8-K
27 Sep, 2022	8-K/A
1 Sep, 2022	8-K
12 Aug, 2022	10-Q
11 Aug, 2022	8-K
21 Jul, 2022	SC 13D
12 Jul, 2022	8-K
29 Jun, 2022	8-K
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	8-K
21 Jun, 2022	8-K
11 May, 2022	10-Q
10 May, 2022	8-K
29 Apr, 2022	DEF 14A
29 Apr, 2022	DEFA14A
28 Apr, 2022	4
26 Apr, 2022	8-K
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
5 Apr, 2022	4
4 Apr, 2022	8-K
1 Apr, 2022	S-8
25 Mar, 2022	3
11 Mar, 2022	S-8
11 Mar, 2022	10-K
10 Mar, 2022	8-K
28 Feb, 2022	8-K
25 Feb, 2022	8-K
16 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
15 Feb, 2022	4
14 Feb, 2022	4
14 Feb, 2022	4
14 Feb, 2022	4
14 Feb, 2022	4
14 Feb, 2022	4
11 Feb, 2022	SC 13G
10 Feb, 2022	SC 13G
7 Feb, 2022	SC 13G
31 Jan, 2022	SC 13G
13 Jan, 2022	SC 13G/A
12 Jan, 2022	4
12 Jan, 2022	8-K
12 Jan, 2022	3
27 Dec, 2021	8-K
22 Nov, 2021	8-K
17 Nov, 2021	8-K
10 Nov, 2021	10-Q
9 Nov, 2021	8-K
2 Nov, 2021	3
2 Nov, 2021	4
2 Nov, 2021	4
2 Nov, 2021	3
29 Oct, 2021	S-8
29 Oct, 2021	8-K
26 Oct, 2021	8-K
18 Oct, 2021	8-K
18 Oct, 2021	425
24 Sep, 2021	EFFECT
24 Sep, 2021	424B3
22 Sep, 2021	CORRESP
22 Sep, 2021	S-4/A
14 Sep, 2021	UPLOAD
10 Sep, 2021	4
8 Sep, 2021	S-4
30 Aug, 2021	8-K
25 Aug, 2021	8-K
11 Aug, 2021	10-Q
10 Aug, 2021	8-K
30 Jul, 2021	425
29 Jul, 2021	425
29 Jul, 2021	8-K
29 Jul, 2021	8-K
29 Jul, 2021	425
29 Jul, 2021	425
19 Jul, 2021	4
19 Jul, 2021	3
14 Jul, 2021	8-K
13 May, 2021	10-Q
12 May, 2021	8-K
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
5 Apr, 2021	4
31 Mar, 2021	8-K
29 Mar, 2021	8-K
26 Mar, 2021	10-K
17 Mar, 2021	SC 13G
17 Feb, 2021	8-K
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
16 Feb, 2021	4
12 Feb, 2021	3
12 Feb, 2021	424B4	IPO completed
12 Feb, 2021	SEC STAFF
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	3
11 Feb, 2021	8-A12B
11 Feb, 2021	CERT
11 Feb, 2021	S-8
10 Feb, 2021	CORRESP
10 Feb, 2021	S-1/A
10 Feb, 2021	EFFECT
10 Feb, 2021	S-1MEF
9 Feb, 2021	UPLOAD
8 Feb, 2021	CORRESP
8 Feb, 2021	CORRESP
4 Feb, 2021	S-1/A
1 Feb, 2021	CORRESP
27 Jan, 2021	SEC STAFF
20 Jan, 2021	S-1
30 Dec, 2020	DRSLTR
19 Nov, 2020	SEC STAFF
18 Nov, 2020	UPLOAD
10 Nov, 2020	DRS/A
9 Nov, 2020	DRSLTR
2 Nov, 2020	UPLOAD
6 Oct, 2020	DRS

Last update:2024-03-08 12:07:48.495771

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.